TransMedics Group, Inc. Common Stock

Go to TransMedics Group, Inc. Common Stock Website

$121.25

2.28 (1.92%)
Live
Previous Close

$120.55

Day Range

$114.28 - $122.76

Previous Day Range

$111.3 - $124.5

Market Cap

$4.1 billion USD

Day Vol.

1.8 million

Previous Day Vol.

3.9 million

Currency

USD

Primary Exchange

Nasdaq

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address t...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

TransMedics reported impressive Q2 results with 38% revenue growth, doubled earnings per share, and raised full-year sales guidance. The company's Organ Care System continues to show promise in organ transplant technology, with potential for further international market expansion.

Related tickers: TMDX.

Read Full Article

TransMedics Group reported strong Q2 2025 financial results, with 38% revenue growth, beating analyst estimates. The company raised full-year revenue guidance and continues to expand its Organ Care System technology and National OCS Program logistics business.

Related tickers: TMDX.

Read Full Article
Trending Tickers

Please sign in to view